Issues related to pharmaceutical pricing and transparency. Issues relating to Medicare Part D Pricing Reform. Issues relating to Part B pricing reform. Issues related to Medicaid pricing. Issues related to promoting value based arrangements in Medicare.
S.474 - SPIKE Act of 2019
S. 476 - C-Thru Act of 2019
S.475 -Rx Cap Act of 2019
S.62 - Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
JONATHON JONES JOHN MICHAEL GONZALEZ SEAN RICHARDSON JONATHON JONES JOHN MICHAEL GONZALEZ SEAN RICHARDSON